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We have studied the effects of synthetic p-human atria1 natriuretic peptide (j?-hANP), an antiparallel dimer 
of a-hANP, on receptor binding and cGMP generation in cultured rat vascular smooth muscle cells and 
compared the effects with those of a-hANP. Characteristics of temperature-dependent binding and degrada- 
tion of 1Z51-~-hANP were similar to those of lZSI-a-hANP. Scatchard analysis indicated a single class of bind- 
ing sites for b-hANP with a maximal binding capacity one-half that of a-hANP. Parallel and antiparallel 
dimers were equipotent in inhibiting the binding and stimulating intracellular cGMP formation, of which 
the maximal effect was about one-half that of a-hANP. Reverse-phase high performance liquid chromato- 
graphy revealed that most of b-hANP added to cells was converted to a small molecular mass component 
corresponding to a-hANP after incubation. These data suggest that the less potent effect of p-hANP in re- 
ceptor binding and cGMP generation may be partly accounted for by the possible conversion of /J-hANP 
to a-hANP at the site of target cells. 
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1. INTRODUCTION 
In human atria, three distinct forms of human 
atria1 natriuretic peptide (hANP) have been iden- 
tified [1,2]: (Y (28 residues), p (56 residues), and y 
(126 residues). a-hANP is the major cardiac hor- 
mone with a potent natriuretic and vasoactive ac- 
tivity [l], while y-hANP having the sequence of 
cu-hANP at its C-terminus, is a precursor molecule 
for a-hANP [2,3]. In contrast, P-hANP comprises 
an antiparallel dimer of cu-hANP [2], although 
whether such a dimetric peptide processing occurs 
in vivo remains unknown. Recently, /?-hANP has 
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been synthesized and its biological activity has 
been determined [4,5]. Interestingly, natural [2] as 
well as synthetic fi-hANP [4,5] exhibits a slower 
onset and longer duration of action than a-hANP, 
the mechanism of which remains obscure. 
Using cultured rat vascular smooth muscle cells 
(VSMCs) which have specific receptors for ANP 
functionally coupled to the guanylate cyclase 
system [6], we have clarified the cellular 
mechanism of binding, internalization and 
degradation of a-rat (r) ANP [7]. To elucidate the 
mechanism by which ,&hANP acts on the target 
cell, we have studied the effects of synthetic ,& 
hANP on receptor binding and cGMP generation 
in cultured rat VSMCs in comparison with that of 
cr-hANP, and examined the change in molecular 
size of P-hANP coincubated with the cells. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Antiparallel (,&hANP) and parallel dimers of a- 
hANP were synthesized by a conventional solution 
method as reported [4]. Synthetic cu-hANP was 
also obtained from Peptide Institute (Osaka, 
Japan). Iodination of a-hANP and ,&hANP was 
performed by the lactoperoxidase method [6] with 
specific activities of - 150 ,uCi/,ug and -50 &i/,ug, 
respectively. 
2.2. Binding experiment 
Rat aortic VSMCs were cultured and used in the 
experiments as reported [6]. Confluent cells 
(0.5-l x lo6 cells) were incubated with 1z51-~- 
hANP or ‘*‘I-,&-hANP in Hanks’ balanced salt 
solution, pH 7.4, containing 0.1% bovine serum 
albumin (binding medium) at 4°C for 3 h to 
minimize internalization and/or degradation of 
radioligand. After completion, cells were washed, 
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Fig. 1. Time course of specific binding of “‘I-(U-hANP 
and “‘1-fl-hANP to cultured rat VSMCs at 37°C and 
4°C. Confluent cells (lo6 cells) were incubated with 
2 nM “‘1-Cy-hANP (A) and ‘251-fl-hANP (B) at 37°C 
(0) or 4°C (0). At the indicated times, specific cell- 
bound radioactivity was determined; each point is the 
Fig.2. Time course of decrease of cell-bound ‘25I-~- 
hANP and ‘251-fi-hANP from cultured rat VSMCs at 
37°C and 4°C. After preincubation with 1 nM 1251~- 
hANP (A) and ‘251-/3-hANP (B) at 4°C for 3 h, cells 
were further incubated in fresh medium at 37°C (0) or 
4°C (0). At the indicated times, the cell-bound 
radioactivity was determined. The results are expressed 
as the percentage of binding at indicated time intervals 
to initial binding; each point is the mean of duplicate 
dishes. Specific binding of “‘I-a-hANP and 1251-@- 
hANP at zero time was 85% and 50% of total binding, 
mean of triplicate dishes. respectively. 
solubilized with NaOH, and cell-bound radioac- 
tivity was determined. Specific binding was defin- 
ed as total binding minus nonspecific binding in 
the presence of excess (3.2 x lo-’ M) unlabeled a- 
hANP or P-hANP. 
2.3. Internalization and degradation 
To study degradation, the cells were prein- 
cubated with radioligands at 4°C for 3 h, rinsed, 
and then incubated at either 37°C or 4°C; the cell- 
bound radioactivity was determined and 
trichloroacetic acid-insoluble radioactivity was 
also measured in aliquots of the medium. For 
analysis of internalization, prebound radioligand 
was dissociated with 0.1 M acetic acid treatment 
that only extracts surface-bound, but not inter- 
nalized ligands [7,8]. 
2.4. Determination of intracellular cGMP 
VSMCs were incubated with or without various 
doses of cu-hANP or fl-hANP at 37°C for 10 min 
in binding medium containing 0.5 mM 
methylisobutylxanthine [6]. Intracellular cGMP 
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2.5. Chromatographic analysis 3. RESULTS 
To examine whether the change in molecular size 
of exogenous ,&-hANP occurs during incubation, 
the media in which P-hANP was coincubated with 
or without VSMCs at 37°C for 60 min were ap- 
plied to a Sep-Pak Cis cartridge (Waters Associate, 
Milford, MA) followed by washing with distilled 
water and elution with 5 ml of 86% ethanolM% 
acetic acid. The eluate was evaporated to dryness 
under nitrogen gas and subjected to reverse-phase 
high pressure liquid chromatography (HPLC) on a 
4.6 x 250 mm Zorbax ODS column (DuPont Co., 
Wilmington, DE) with a linear gradient from 10 to 
60% acetonitrile for 80 min. The flow rate was 
1 ml/min; l-ml fractions were collected. The 
eluates were dried and assayed for hANP by RIA 
as described in [9]. Lu-hANP RIA was performed 
using rabbit ant&-hANP antiserum that showed 
50% cross-reactivity with ,&-hANP on a molar 
Binding of ‘251_cy-hANP and “‘1-fi-hANP to 
cultured rat VSMCs showed almost similar 
temperature- and time-dependency (fig. 1); at 37°C 
binding of both radioligands rapidly reached to a 
maximum at 15-30 min and decreased thereafter, 
while their maximal binding at 4°C was slow 
(3-4 h) but about 3-4-fold greater than that at 
37°C. Specific binding of “‘I_Cy-hANP and ‘251-& 
hANP was 90-95% and 50-60% of total binding, 
respectively. The prebound radioactivity of either 
i2’I-cu-hANP or 1251-fl-hANP at 4°C after 
washing, decreased more rapidly upon warming 
the cells to 37°C than further incubation at 4°C 
(fig.2); most (> 80%) radioactive material released 
into medium at 37°C was trichloroacetic acid- 
soluble, while at 4°C it was exclusively 
trichloroacetic acid-insoluble. Furthermore, about 
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Fig.3. Saturable binding of ?_Cy-hANP and ‘2sI-,!3-hANP to cultured rat VSMCs. Confluent cells (lo6 cells) were 
incubated with various doses of lz51-Cy-hANP (A) and ‘251-fl-hANP (B) at 4°C for 3 h. Specific binding of ‘251-cy-hANP 
and ‘251-/3-hANP was 80-90% and 50-60% of total binding, respectively. Each point is the mean of two experiments. 
(Insets) Scatchard plots of binding data. KD, dissociation constant; B,,,, number of maximal binding sites per cell. 
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hANP at 37°C shifted to the acid-resistant com- 
partment, whereas at 4°C they were mostly loca- 
lized on the acid-extractable compartment (not 
shown). These experiments suggest that, after 
washing, the observed temperature-dependent 
decrease of cell-bound radioactivity is most 
probably due to internalization, degradation, and 
elimination of ligands rather than simple dissocia- 
tion from the cell surface as demonstrated [7]. 
An equilibrium binding of ‘251-cr-hANP and 
1251-@-hANP at 4°C was a saturable process 
(fig.3). Scatchard plots of the binding (fig.3, inset) 
revealed the presence of a single class of binding 
sites for both a-hANP and ,&hANP: the apparent 
dissociation constants (&) were almost the same 
(-2 x 10m9 M), while the maximal binding sites 




Fig.4. Competitive binding of rz51-cy-hANP and “‘I-fl- 
hANP to cultured rat VSMCs by unlabeled a-hANP and 
fl-hANP. Confluent cells (5 x 10’ cells) were incubated 
at 4°C for 3 h with 1 nM ‘251-cy-hANP (A) and ‘251-fl- 
hANP (B) in the absence and presence of various doses 
of unlabeled cu-hANP (o), its antiparallel (0) and 
parallel (A) dimers. Results are expressed as the 
percentage to specific binding in the absence of peptides 
(B,,); each point is the mean of duplicate dishes. Specific 
binding of “‘I--hANP and ‘251-fl-hANP was 98% and 




Fig.5. Effects of a-hANP and P-hANP on formation of 
intracellular cGMP in cultured rat VSMCs. Confluent 
cells (5 x lo5 cells) were incubated at 37°C for 10 min 
in the absence (@) and presence of various doses of (Y- 
hANP (o), its antiparallel (0) and parallel (A) dimers. 
Concentrations of intracellular cGMP were determined 
by RIA. Each point is the mean of three samples: bar 
shows SE. 
of cu-hANP (206000 sites/cell). Competitive 
binding of ‘251-cy-hANP (fig.4A) and tZ51-fi-hANP 
(fig.4B) by unlabeled a-hANP and its dimers was 
studied; parallel and antiparallel dimers equally in- 
hibited the binding of both radioligands with 
almost the same ICsO (-1-2 x lop9 M), but they 
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Fig.6. An elution profile of reverse-phase HPLC. The 
medium in which&hANP was coincubated with VSMCs 
at 37°C for 60 min was subjected to a reverse-phase 
HPLC. Concentrations of immunoreactive (IR) hANP 
were determined. Arrows denote the elution positions of 
standard cu-hANP (cu) and ,&hANP c4), respectively. 
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displacing both radioligands from their binding 
sites. 
As shown in fig.5, parallel and antiparallel 
dimers were equipotent in stimulating cGMP for- 
mation with an approximate ECso (-5 x lo-’ M) 
comparable to that of cu-hANP, whereas the max- 
imal stimulation on cGMP generation by two 
dimers was about one-half that by a-hANP. 
Reverse-phase HPLC of the medium in which fi- 
hANP was coincubated with cells revealed two im- 
munoreactive (IR) peaks (fig.6); a major peak 
comprising about two-third of total immunoreac- 
tivity emerged at the elution position of standard 
a-hANP, while a minor peak comigrated with 
standard /3-hANP. When &hANP was incubated 
in the same medium without cells, only the single 
IR peak coeluting with standard ,&hANP was 
observed (not shown). 
4. DISCUSSION 
It has recently been shown that synthetic p- 
hANP, an antiparallel dimer of cu-hANP, has 
biological properties similar to natural ,&hANP 
[4,5]. The present study first demonstrates that 
synthetic &hANP binds to cultured rat VSMCs in 
the same manner as a-hANP in terms of time- and 
temperature-dependency. Furthermore, the pre- 
sent binding experiments suggest that both (Y- 
hANP and P-hANP initially bound to cell-surface 
membranes are similarly internalized, degraded, 
and subsequently released into medium in a 
temperature-dependent manner. In fact, degrada- 
tion of cell-bound 1251-fi-hANP at 37°C was 
significantly blocked by pretreatment with 
lysosomotrophic drugs (NHdCl, chloroquine) and 
an autoradiographic study using electron 
microscopy revealed that grains of “‘1-fl-hANP 
were localized not only on the cell membrane, but 
also within lysosome-like structures at 37°C (un- 
published observations). Taken together, our data 
are consistent with the cellular mechanism of 
binding, internalization and degradation of p- 
hANP similar to that of cu-rANP as we have 
demonstrated [7]. Therefore, it seems unlikely that 
altered binding affinity and/or delayed degrada- 
tion of ,&hANP may be responsible for the observ- 
ed slower onset and longer duration of action by 
,&hANP [2,4,5]. 
While we have reported that only a small quanti- 
ty (2-3%) of ,&hANP is converted to a-hANP 
under in vitro conditions [4], the present study 
clearly shows that most of the P-hANP added to 
VSMCs in a serum-free condition is eventually 
converted to a small molecular sized component 
corresponding to a-hANP, suggesting the possible 
conversion from dimeric into monomeric form 
during incubation. Therefore, it seems likely that 
the observed slower onset and longer duration of 
&hANP action [2,4,5] may be in part accounted 
for by the conversion of ,&hANP to a-hANP at the 
site of target organs and/or in the circulation. 
However, whether the cleavage of intermolecular 
disulfide bonds of ,&hANP and reformation of an 
intramolecular disulfide bond of cr-hANP involve 
cell-mediated enzymatic processing remains to be 
determined. 
In the present studies, maximal binding capacity 
of ,&hANP is shown to be one-half that of cy- 
hANP, while the apparent binding affinity is 
almost the same. This is in accord with our result 
that the maximal stimulatory effects of in- 
tracellular cGMP formation by parallel and an- 
tiparallel dimers, although almost identical with 
one another, appear to be about half that by a- 
hANP. These data are also compatible with those 
of biological activities of P-hANPs [4,5]; parallel 
and antiparallel forms are equipotent but equally 
less potent than a-hANP in smooth muscle 
spasmolytic in vitro assays as well as natriuretic in 
vivo assays. Assuming that @hANP is fully con- 
vertible to a-hANP that interacts with its receptor 
and stimulates guanylate cyclase, P-hANP should 
be twice as active as a-hANP on a molar basis. 
However, this is not the case because &hANP 
bound only to half the receptor population. One 
would thus speculate that about one-fourth of the 
dimeric form may be convertible to the monomeric 
form to explain the less potent effect of fl-hANP in 
receptor binding and cGMP generation. The 
precise mechanism by which P-hANP is converted 
into cu-hANP in vivo remains to be elucidated. 
ACKNOWLEDGEMENTS 
This study was supported in part by Research 
Grants from the Ministry of Health and Welfare 
and the Ministry of Education, Science and 
Culture, Japan. We thank MS M. Fukushima and 
S. Kaizuka for technical assistance. 
373 
Volume 219, number 2 FEBS LETTERS July 1987 
REFERENCES 
[l] Kangawa, K. and Matsuo, H. (1984) Biochem. Bio- 
phys. Res. Commun. 118, 131-139. 
[2] Kangawa, K., Fukuda, A. and Matsuo, H. (1985) 
Nature 313, 397-400. 
[3] Oikawa, S., Imai, M., Ueno, A., Tanaka, S., 
Noguchi, T., Nakazato, H., Kangawa, K., Fukuda, 
A. and Matsuo, H. (1984) Nature 309, 724-726. 
[4] Chino, N., Yoshizawa-Kumagaye, K., Noda, Y., 
Watanabe, T.X., Kimura, T. and Sakakibara, S. 
(1986) Biochem. Biophys. Res. Commun. 141, 
665-672. 
[5] Kobayashi, Y., Kawabata, T., Hara, S., Yamauchi, 
A., Ueda, A., Kono, M., Doteuchi, M., Nakamura, 
M. and Inoue, K. (1986) FEBS Lett. 206, 313-318. 
[6] Hirata, Y., Tomita, M., Yoshimi, H. and Ikeda, M. 
(1984) Biochem. Biophys. Res. Commun. 125, 
562-568. 
[7] Hirata, Y., Takata, S., Tomita, M. and Takaichi, S. 
(1985) Biochem. Biophys. Res. Commun. 132, 
976-984. 
[8] Haigler, H.T., Maxfield, F.R., Willingham, M.C. 
and Pastan, I. (1980) J. Biol. Chem. 225, 
1239-1241. 
[9] Kojima, T., Hirata, Y., Iwase, S. and Kobayashi, Y. 
(1987) Arch. Dis. Child., in press. 
374 
